Surgical Science Sweden AB (publ)
SUS
Rank in Stocks
#14501
Surgical Science Sweden AB (publ) specializes in the creation and distribution... Surgical Science Sweden AB (publ) specializes in the creation and distribution of virtual reality (VR) simulation platforms designed for evidence-backed training in laparoscopic and endoscopic procedures. Among its key offerings is the LapSim training system, which includes LapSim ST, tailored for educating surgical technologists and assistants, as well as LapSim essence, a compact and readily deployable VR simulator. The company's product portfolio further extends to the EndoSim system, a dedicated endoscopy simulator for comprehensive medical training. It also features TeamSim, an innovative platform fostering inter-professional education by integrating surgical simulation with real-world team dynamics. Additionally, they provide the Simball Box, which delivers velocity feedback alongside instructional task videos demonstrating optimal techniques, alongside their well-known Simbionix and robotic surgery simulators. Established in 1999, Surgical Science AB maintains its headquarters in Gothenburg, Sweden.
Share Price
$6.26
Last synced: 2026-11-09
Market Cap
$319.39M
Change (1 day)
0.43%
Change (1 year)
-28.67%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Surgical Science Sweden AB (publ) (SUS)
Category
Healthcare
Operating Margin for Surgical Science Sweden AB (publ) (SUS)
Operating Margin as of November 2026 TTM: 13.77%
According to Surgical Science Sweden AB (publ)'s latest financial reports, its current operating margin (TTM) is 13.77%. At the end of 2025 the company had an operating margin of 10.98%.
Operating Margin history for Surgical Science Sweden AB (publ) from 2014 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 13.77% | 25.41% |
| 2025 | 10.98% | -32.72% |
| 2024 | 16.32% | -23.85% |
| 2023 | 21.43% | 5.83% |
| 2022 | 20.25% | -16.32% |
| 2021 | 24.20% | 26.97% |
| 2020 | 19.06% | 27.49% |
| 2019 | 14.95% | -341.52% |
| 2018 | -6.19% | -3.88% |
| 2017 | -6.44% | 1,551.28% |
| 2016 | -0.39% | -110.00% |
| 2015 | 3.90% | -154.39% |
| 2014 | -7.17% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 13.21% | -99.04% |
US
|
|
| -19.76% | -101.44% |
US
|
|
| 74.94% | -94.56% |
AU
|
|
| 3.61% | -99.74% |
US
|
|
| 13.01% | -99.06% |
US
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Surgical Science Sweden AB (publ)'s operating margin
What is Surgical Science Sweden AB (publ)'s operating margin?
Surgical Science Sweden AB (publ)'s operating margin is 13.77%, as of Nov 2026.
What was Surgical Science Sweden AB (publ)'s operating margin in 2025?
In 2025, Surgical Science Sweden AB (publ)'s operating margin was 10.98%, compared with 16.32% in 2024.
How has Surgical Science Sweden AB (publ)'s operating margin changed since 2020?
From 2020 to 2025, Surgical Science Sweden AB (publ)'s operating margin was highest in 2021 (24.20%) and lowest in 2025 (10.98%).
How does Surgical Science Sweden AB (publ)'s operating margin compare with similar companies?
Surgical Science Sweden AB (publ)'s operating margin (13.77%) is higher than that of 4 of the 5 similar companies listed above. The highest among them is Pro Medicus Limited, with 74.94%.